|
|
405 Britannia Road East, Suite 106
Mississauga, Ontario L4Z 3E6 Canada
phone:(1) 905 568 8400
fax:(1) 905 568 5200
|
|
| Symbol |
COV |
| Exchange |
TSX |
| Founded |
0 |
| Employees |
|
|
|
| www.covalon.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Biomaterials for wound care and surgical applications. |
|
| Management |
| Frank DiCosmo, Ph.D., President and Chief Executive Officer; William Jackson, Chief Financial Officer and Chief Operating Officer; Valerio DiTizio, Ph.D., Chief Scientific Officer; Sonia Sanhueza, Ph.D., Chief Operating Officer; Peter Hobbes, C.A.,
Chief Financial Officer |
| |
|
|
|
|
|
|
|
| Keywords |
| woundwound, woundcare |
|
|
|
| Description |
|
Covalon Technologies developes therapeutic biomaterials for wound care and surgical applications and coatings. |
|
| Products / Services |
Covalon's products include covalently cross-linked denatured collagen platforms for various applications for drug delivery and hydrophilic, lubricious and durable coatings for polymeric medical devices.
|
|
| Technology / Differentiation |
| Polymer chemistry and surface coating technology have been combined to create a range of time-release drug delivery platforms. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
